These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9240682)

  • 1. Magnetic iron oxide particles coated with carboxydextran for parenteral administration and liver contrasting. Pre-clinical profile of SH U555A.
    Lawaczeck R; Bauer H; Frenzel T; Hasegawa M; Ito Y; Kito K; Miwa N; Tsutsui H; Vogler H; Weinmann HJ
    Acta Radiol; 1997 Jul; 38(4 Pt 1):584-97. PubMed ID: 9240682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging of liver metastases: experimental comparison of anionic and conventional superparamagnetic iron oxide particles with a hepatobiliary contrast medium during dynamic and uptake phases.
    Kaufels N; Korn R; Wagner S; Schink T; Hamm B; Taupitz M; Schnorr J
    Invest Radiol; 2008 Jul; 43(7):496-503. PubMed ID: 18580332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RES-specific imaging of the liver and spleen with iron oxide particles designed for blood pool MR-angiography.
    Bremer C; Allkemper T; Baermig J; Reimer P
    J Magn Reson Imaging; 1999 Sep; 10(3):461-7. PubMed ID: 10508309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance of iron oxide particles in rat liver: effect of hydrated particle size and coating material on liver metabolism.
    Briley-Saebo KC; Johansson LO; Hustvedt SO; Haldorsen AG; Bjørnerud A; Fayad ZA; Ahlstrom HK
    Invest Radiol; 2006 Jul; 41(7):560-71. PubMed ID: 16772849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of superparamagnetic iron-oxide MR contrast agents in the rat.
    Majumdar S; Zoghbi SS; Gore JC
    Invest Radiol; 1990 Jul; 25(7):771-7. PubMed ID: 2391194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver-directed superparamagnetic iron oxide: quantitation of T2 relaxation effects.
    Pouliquen D; Lucet I; Chouly C; Perdrisot R; Le Jeune JJ; Jallet P
    Magn Reson Imaging; 1993; 11(2):219-28. PubMed ID: 8455432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits.
    Taupitz M; Schnorr J; Abramjuk C; Wagner S; Pilgrimm H; Hünigen H; Hamm B
    J Magn Reson Imaging; 2000 Dec; 12(6):905-11. PubMed ID: 11105029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
    Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
    Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term imaging effects in rat liver after a single injection of an iron oxide nanoparticle based MR contrast agent.
    Briley-Saebø K; Hustvedt SO; Haldorsen A; Bjørnerud A
    J Magn Reson Imaging; 2004 Oct; 20(4):622-31. PubMed ID: 15390223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
    Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
    Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide.
    Hamm B; Staks T; Taupitz M; Maibauer R; Speidel A; Huppertz A; Frenzel T; Lawaczeck R; Wolf KJ; Lange L
    J Magn Reson Imaging; 1994; 4(5):659-68. PubMed ID: 7981510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance lymphography in rats: effects of muscular activity and hyperthermia on the lymph node uptake of intravenously injected superparamagnetic iron oxide particles.
    Elste V; Wagner S; Taupitz M; Pfefferer D; Kresse M; Hamm B; Berg R; Wolf KJ; Semmler W
    Acad Radiol; 1996 Aug; 3(8):660-6. PubMed ID: 8796730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superparamagnetic iron oxide for liver imaging. Comparison among three different preparations.
    Bach-Gansmo T; Fahlvik AK; Ericsson A; Hemmingsson A
    Invest Radiol; 1994 Mar; 29(3):339-44. PubMed ID: 8175309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging.
    Shamsi K; Balzer T; Saini S; Ros PR; Nelson RC; Carter EC; Tollerfield S; Niendorf HP
    Radiology; 1998 Feb; 206(2):365-71. PubMed ID: 9457187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of fast and ultrafast T2-weighted MR imaging sequences in hepatic enhancement with ferumoxides: comparison with conventional spin-echo sequence.
    Abe Y; Yamashita Y; Namimoto T; Tang Y; Takahashi M
    Radiat Med; 2000; 18(2):97-105. PubMed ID: 10888042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodistribution of ultrasmall iron oxide particles in the rat liver.
    Van Beers BE; Sempoux C; Materne R; Delos M; Smith AM
    J Magn Reson Imaging; 2001 Apr; 13(4):594-9. PubMed ID: 11276104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles.
    Grangier C; Tourniaire J; Mentha G; Schiau R; Howarth N; Chachuat A; Grossholz M; Terrier F
    J Comput Assist Tomogr; 1994; 18(6):888-96. PubMed ID: 7962795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a blood-pool contrast agent for MR-guided vascular procedures: feasibility of ultrasmall superparamagnetic iron oxide particles.
    Wacker FK; Wendt M; Ebert W; Hillenbrandt C; Wolf KJ; Lewin JS
    Acad Radiol; 2002 Nov; 9(11):1251-4. PubMed ID: 12449357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of hepatomas in hyperplastic nodules induced in the rat liver: detection with superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Yamamoto H; Yamashita Y; Takahashi M
    Acad Radiol; 1996 Apr; 3(4):330-5. PubMed ID: 8796683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
    Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D
    AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.